Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group - 01/12/15
Doi : 10.1016/S1470-2045(15)00166-7
Isabelle Thibault, MD a, Eric L Chang, ProfMD b, Jason Sheehan, ProfMD c, Manmeet S Ahluwalia, MD d, Matthias Guckenberger, ProfMD g, h, Moon-Jun Sohn, MD i, Samuel Ryu, ProfMD j, Matthew Foote, MBBS k, Simon S Lo, ProfMB ChB l, Alexander Muacevic, ProfMD m, Scott G Soltys, MD n, Samuel Chao, MD e, Peter Gerszten, ProfMD o, Eric Lis, MD p, Eugene Yu, MD r, Mark Bilsky, ProfMD q, Charles Fisher, ProfMD s, David Schiff, ProfMD t, Michael G Fehlings, ProfMD u, Lijun Ma, ProfPhD v, Susan Chang, ProfMD w, Edward Chow, ProfMBBS x, Wendy R Parelukar, MD y, Michael A Vogelbaum, ProfMD f, Arjun Sahgal, DrMD x, ⁎ 
a Department of Radiation Oncology, Centre Hospitalier Universitaire de Quebec, Université Laval, Quebec City, QC, Canada
b Department of Radiation Oncology, University of Southern California, Los Angeles, CA, USA
c Department of Neurosurgery, University of Virginia Health System, Charlottesville, VA, USA
d Department of Medical Oncology, Cleveland Clinic, Cleveland, OH, USA
e Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA
f Brain Tumor and Neuro-Oncology Center and Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, USA
g Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
h Department of Radiation Oncology, University Hospital Wuerzburg, Wuerzberg, Germany
i Department of Neurosurgery, Inje University Ilsan Paik Hospital, Goyang, Korea
j Department of Radiation Oncology, Stony Brook University, New York, NY, USA
k Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia
l Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA
m Department of Neurosurgery, University of Munich Hospital, Munich, Germany
n Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA
o Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
p Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
q Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
r Department of Radiology, University Health Network, Toronto, ON, Canada
s Department of Orthopedics, University of British Columbia, Vancouver, BC, Canada
t Division of Neuro-Oncology, University of Virginia Health System, Charlottesville, VA, USA
u Department of Neurosurgery, Toronto Western Hospital, Toronto, ON, Canada
v Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA
w Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA
x Department of Radiation Oncology, University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada
y NCIC Clinical Trials Group Division, Cancer Research Institute, Queen’s University Kingston, ON, Canada
* Correspondence to: Dr Arjun Sahgal, Department of Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada Correspondence to: Dr Arjun Sahgal Department of Radiation Oncology University of Toronto Sunnybrook Health Sciences Centre 2075 Bayview Avenue Toronto ON M4N 3M5 Canada
Summary |
The SPine response assessment In Neuro-Oncology (SPINO) group is a committee of the Response Assessment in Neuro-Oncology working group and comprises a Panel of international experts in spine stereotactic body radiotherapy (SBRT). Here, we present the group’s first report on the challenges in standardising imaging-based assessment of local control and pain for spinal metastases. We review current imaging modalities used in SBRT treatment planning and tumour assessment and review the criteria for pain and local control in registered clinical trials specific to spine SBRT. We summarise the results of an international survey of the Panel to establish the range of current practices in assessing tumour response to spine SBRT. The ultimate goal of the SPINO group is to report consensus criteria for tumour imaging, clinical assessment, and symptom-based response criteria to help standardise future clinical trials.
Le texte complet de cet article est disponible en PDF.Plan
© 2015
Elsevier Ltd. Tous droits réservés.
Vol 16 - N° 16
P. e595-e603 - décembre 2015 Retour au numéro
Article précédent
- Afatinib alone or afatinib plus vinorelbine versus investigator’s choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
- Javier Cortés, Véronique Dieras, Jungsil Ro, Jérôme Barriere, Thomas Bachelot, Sara Hurvitz, Emilie Le Rhun, Marc Espié, Sung-Bae Kim, Andreas Schneeweiss, Joo Hyuk Sohn, Jean-Marc Nabholtz, Pirkko-Liisa Kellokumpu-Lehtinen, Julie Taguchi, Federico Piacentini, Eva Ciruelos, Petri Bono, Mahmoud Ould-Kaci, Flavien Roux, Heikki Joensuu
- Classification of treatment-related mortality in children with cancer: a systematic assessment
- Sarah Alexander, Jason D Pole, Paul Gibson, Michelle Lee, Tanya Hesser, Susan N Chi, Christopher C Dvorak, Brian Fisher, Henrik Hasle, Jukka Kanerva, Anja Möricke, Bob Phillips, Elizabeth Raetz, Carlos Rodriguez-Galindo, Sujith Samarasinghe, Kjeld Schmiegelow, Wim Tissing, Thomas Lehrnbecher, Lillian Sung, International Pediatric Oncology Mortality Classification Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?